Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share (the "Common Stock")
-
Shares outstanding
-
62,650,155
-
Number of holders
-
222
-
Total 13F shares, excl. options
-
54,096,461
-
Shares change
-
+1,115,141
-
Total reported value, excl. options
-
$2,543,396,226
-
Value change
-
+$53,758,888
-
Put/Call ratio
-
71%
-
Number of buys
-
100
-
Number of sells
-
92
-
Price
-
$47.02
Institutional Holders of Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) as of Q2 2023
As of 30 Jun 2023 Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) had 222 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 54,096,461 shares of stock of the company.
Largest 10 holders included FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, BlackRock Inc., Bellevue Group AG, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, JPMORGAN CHASE & CO, Boxer Capital, LLC, and PRICE T ROWE ASSOCIATES INC /MD/.
This table shows 222 institutional shareholders of the security as of 30 Jun 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.